DIETZ Flashcards
Glucuronidation
Phase 2 Reaction
Most common
Addition of Sugar
detoxification of xenobiotics
–> phenols / alochols
–> aromatic amines / acids
Sulfate Conjugation
Phase 2 Reaction
Addition of Inorganic Sulfate
sulfate concentration is LIMITED, glucuronidation is more common
–> Phenols (most common) / alcohols
–> aromatic amines
Glutathione Conjugation
Phase 2 Reaction
Most common route for removal of Electrophiles
Major Detoxification Reaction
GSH - resistant to peptidases due to gamma linkage
Gamma lInkage prevents from peptidase degradation
Glutamine y-linkage + Cysteine + Glycine = GSH
Drug = Electrophile
GSH = Nucleophile
Glucuronide Conjugation
Enzymes & Cofactors
Conjugates glucuronic acid w/
billirubin / drugs / pesticides / carcinogens
Enzyme = UGT1 / UGT2
Catalyst = UDP
Co-factor = UDPGA
found in: liver / intestines / kidney / skin / brain / spleen/ nasal mucosa
Glucoronide Conjugation
Mechanism
- Step 1) Formation of UDPGA
- alpha glucose phosphate –> activated glucoronic acid
- Step 2) Sn2 Displacement reaction
- UDPGA = Electrophile
- Drug/Substrate = Nucleophile
- Enzyme = UGT –> UDT
- INVERSION OF ALPHA –> BETA
- product is always beta conjugate
Glucorinide Conjugation
UGT Substrates
Substrate = Nucleophile
UGT = electrophile
–> Produce ether linkage = polar metabolite
water soluble / excreted in kidney
-
Alcohols
- 1* / 2* mainly
- Phenols
-
Acids
- Both aliphatic & aromatic
-
Amines
- mainly aromatic
- produce –> N-glucuronide
Crigler-Najjar Syndrome
Gilberts Disease
- Caused by a deficiency in** **UGT
- UGT conjugates unconjugated bilirubin
- –> High concentration of unconj. Bilirubin
Gray Baby Syndrome
- Caused by neonate inability to conjugate CHLORAMPHENICOL
- antibacterial that needs UGT to break it down
- UGT Deficiency
UGT Polymorphism
UGT1A1*28 Varient
Express Less UGT1A1 Enzyme
-
–> can lead to nonhemolytic unconjugated HYPERbilirubinemias
- –> Jaundice
- –> decreased enzyme activity effects Drug CLEARANCE
-
IRINOTECAN (anticancer PRODrug)
- –> toxicity = diarrhea/neutropenia
-
IRINOTECAN (anticancer PRODrug)
UGT Enzyme INDUCER
Phenobarbital
UGT Enzyme Inhibitor
Protease Inhibitors
Lopinavir/Ritonavir
Flavonoids (phenolic phytochemicals)
= competitive substrate / inhibitor of UGT
but will need a very high concentration (not seen)
UGT Glucuronidation
Factors
Selective substrates / inibitors are LACKING
Low incidence of UGT Drug-Drug interactions
Important for detoxification reactions
inhibition –> reduce clearance of estradiol/bilirubin
Irinotecan
Prodrug
SN38 Topoisomerase for HIV
-
Protease Inhibitors & lopinavir/ritonavir
-
Inhibit metabolization of SN38 by UGT
- –> INCREASED toxicity
-
lopinavir also inhibits 3A4 metabolism
- –> increased toxicity
-
Inhibit metabolization of SN38 by UGT
How to make a UGT substrate more stable towards Metabolism?
UGT Mechanism is Sn2
to make optimize it (keep it from being metabolized):
+Add Rigidity (sterics)
+Change Stereochemistry
-Reduce Lipohilicity
Why do Glucorinides have a relatively long
HALF LIFE?
Enterohepatic Recycling
-
Glucornides (w/ MW>500)
- –> secreted into BILE
- –> Gallbladder
- –> B-glucoridase (bacterial)
- –> REABSORBED
- –> secreted into BILE
- Ultimately increases time in body and can interact w/ other drugs
- EX. CLORIPHENICOL
Sulfate Conjugation
Enzymes & Cofactors
Detoxification & bioactivation Pathways
Conjugates activated Sulfate to:
–> Phenols
–> alcohols / aromatic amines / N-hydroxyl Groups
Enzyme = SULT1/2
Cofactor = PAPS
found Ubiquitous / LIVER / placenta / intestine
Sulfate Conjugation
Mechanism
-
Step 1: Activation of inorganic sulfate –> PAPS
- ATP-Sulfurylase / APS-Phosphokinase
- –> Active PAPS
- ATP-Sulfurylase / APS-Phosphokinase
-
Step 2: Sn2 Displacement Reaction
- PAPS = Electrophile
- Drug/Substrate = Nucleophile
- Enzyme = ST (sulfotransferase)
- –> Sulfonated Product + PAP
- enhanced water solubility –> excretion
Sulfate Conjugation
of Estradiol
Estradiol + PAPS/ST –> Sulfate Metabolite
- Sulfate Metabolite = Water soluble –> Blood
- In target tissues Sulfatase removes the sulfate
- –> reactivated estradiol in tissue
- “acts as a carrier”
- so drug can travel
- In target tissues Sulfatase removes the sulfate
Sulfate Conjugation
DMBA Bioactivation
DMBA + ST/PAPS –> Sulfate metabolite
- Sulfate –> Sn1 Rxn = Carbocation
- carbocation is highly reactive can form TUMORS
- DNA Adducts
- Carbocation can also –> GSH –> detoxifcation
PAPS / ST
SUBSTRATES
Primarily with PHENOLS
alcohols
aromatic amines
N-hydroxyl groups
Drug = Nucleophile
PAPS = Electrophile
Glutathione Conjugation
Enzyme/Cofactors
Conjugates reactive/soft electrophiles such as
–> epoxides / RX / quinones
–> a/b-unsaturated carbonyls / quinone imines
Enzyme = GST = nu-
alpha/mu/pi-class of GST’s
Cofactor = Glutathione (nu-)
found in basicaly all mammalian tissues
GST Inducers
Phenobarbital
3-methylcholanthrene
Glutathione Conjugation
Mechanism
Can be conjugated w/o prior activation
Detoxification –> Inactive /nontoxic metabolites
-
Sn2 Reaction “INVERTED SN2”
- GST = Nucleophile
- Drug/substrate = electrophile
- Product = Glutathione Conjugate(-GS)
- REDUCES pKa
-
Can further be metabolized
- –>Mercapturic Acid Derivative
Glutathione Conjugation
SUBSTRATES
Elimination of ELECTROPHILES
Epoxides
R-X (alkyl halides)
Quinones (QI’s / QM’s)
alpha/beta -unsaturated carbonyls
GSH = Nucleophile
GSH
Detoxification of Aflatoxins
-
Epoxide (Aflatoxin)
-
strong electrophile –> attack nu- proteins
- –> protein modification
- –> DNA adducts
- Carcinogenic
-
strong electrophile –> attack nu- proteins
-
Epoxide + GST/GSH –> Glutathione Product
- Can be excreted, DETOXIFIED
- *depletion of GST —> more epoxide as a carcinogen
N-Acetyltransferase (NAT)
Reaction
Transfer of Acetyl group to nitrogen atom of:
–> aromatic Amine
–> Hydrazine
Cofactor = Acetyl CoA
Enzyme = NAT
NAT1 found in urothelium / colon epithelial cells
NAT2 found in LIVER / intestine
N-acetyltransferase (NAT)
Mechanism
- Step 1) Transfer of Acetyl CoA –> NAT
-
Step 2) Transfer of Acetyl –> Substrate
- substrate is aromatic amine or hydrazine
- Produces Mercapturic Acid Derivative
- as third step after GST metabolism
NAT
Polymorphisms
Isoniazid (hydrazine group) = Substrate of NAT
- Polymorphism in NAT2 (liver/intestine)
-
SLOW Acetylators
-
–Accumalate Isoniazid –> Neuropathy
- found in many Caucasians /egyptians/moroccans
-
–Accumalate Isoniazid –> Neuropathy
-
RAPID acetylators
-
Isoniazid –> more hydrolysis into acetyl radicals
- –> Hepatic Damage
-
Isoniazid –> more hydrolysis into acetyl radicals
Mercapturic Acid Pathway
-
After GST Conjugation:
- Product has Glutamine / Cysteine / Glycine
- 1) Y-glutamine Amide Hydrolysis
- 2) Glycine Amide Hydrolysis
- 3) Cys-N-Acytylation
- NAT + AcetylCoA
-
PRODUCE MERCAPTURIC ACID
- excreted in urine
- Product has Glutamine / Cysteine / Glycine
Mercapturic Acid Products
Tridiphane = Herbicide
ACETAMINOPHEN
~only 2% of metabolism but is still found as a product
Chemical Toxicology
Drug ITSELF is Toxic
- Exagerated on-target pharmacology
- Off-Target Pharmacology
-
Trigger Immune response
- –> inflammation
- Structure Alerts from toxicity:
- Sulfate
- NO2 (nitrates)
- Aziridiniums
- Epoxides
Fenfluramine
Anti-suppresant drug
Found to cause Rare Valvular Disease
when in combo with Phenteramine
–> potentiation of serotonin effects
DRUG ITSELF WAS TOXIC
Vioxx
COX-2 Inhibitor (similar to Celecoxib)
Increased Risk of CV Problems
COX2–> in endothelial cells –> vessel constriction
DRUG ITSELF WAS TOXIC
DES
(diethylstilbestrol)
Teratogenic Drug
DRUG ITSELF WAS TOXIC
used to prevent miscarriage –> led to increase in CERVICAL CANCER in DES daughters
Endocrine disrupting chemical
–> DNA methylation
Thalidomide
Teratogenic Drug
DRUG ITSELF WAS TOXIC
Used for sleep aid / morning sickness
caused severe birth defects
now used to treat leprosy & considered for HIV / multiple myeloma (cancer)